DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Simtuzumab is an investigational drug.
There have been 6 clinical trials for Simtuzumab. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2011.
The most common disease conditions in clinical trials are Fibrosis, Adenocarcinoma, and Pulmonary Fibrosis. The leading clinical trial sponsors are Gilead Sciences and [disabled in preview].
Recent Clinical Trials for Simtuzumab
|Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3||Gilead Sciences||Phase 2|
|A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF)||Gilead Sciences||Phase 2|
|Long-Term Safety Study of GS-6624 to Treat Idiopathic Pulmonary Fibrosis (IPF)||Gilead Sciences||Phase 2|